These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21756244)

  • 21. A bispecific nanobody to provide full protection against lethal scorpion envenoming.
    Hmila I; Saerens D; Ben Abderrazek R; Vincke C; Abidi N; Benlasfar Z; Govaert J; El Ayeb M; Bouhaouala-Zahar B; Muyldermans S
    FASEB J; 2010 Sep; 24(9):3479-89. PubMed ID: 20410443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab')2.
    Calderón-Aranda ES; Rivière G; Choumet V; Possani LD; Bon C
    Toxicon; 1999 May; 37(5):771-82. PubMed ID: 10219988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New and safe formulation for scorpion immunotherapy: Comparative study between saponin and FCA adjuvants associated to attenuated venom.
    Nouri A; Nait Mohamed FA; Laraba-Djebari F
    Vaccine; 2018 Mar; 36(13):1720-1727. PubMed ID: 29483031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenom for scorpion sting.
    Possani LD
    Lancet; 2000 Jan; 355(9197):67; author reply 67-8. PubMed ID: 10615911
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions.
    Krifi MN; Amri F; Kharrat H; El Ayeb M
    Toxicon; 1999 Nov; 37(11):1627-34. PubMed ID: 10482396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging options for the management of scorpion stings.
    Chippaux JP
    Drug Des Devel Ther; 2012; 6():165-73. PubMed ID: 22826633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of scorpion envenoming: a systematic review and meta-analysis of controlled clinical trials.
    Rodrigo C; Gnanathasan A
    Syst Rev; 2017 Apr; 6(1):74. PubMed ID: 28390429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antivenom for scorpion sting.
    Burdett T; McIntosh H; Murphy K; Parry R; Slater F
    Lancet; 2000 Jan; 355(9197):66-7; author reply 67-8. PubMed ID: 10615910
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of immunogenic characteristics of Hemiscorpius lepturus venom and its cross-reactivity with venoms from Androctonus crassicauda and Mesobuthus eupeus.
    Khanbashi S; Khodadadi A; Assarehzadegan MA; Pipelzadeh MH; Vazirianzadeh B; Hosseinzadeh M; Rahmani AH; Asmar A
    J Immunotoxicol; 2015; 12(3):217-22. PubMed ID: 24946724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy.
    Ismail M
    Toxicon; 1994 Sep; 32(9):1019-26. PubMed ID: 7801336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recombinant antibodies: towards a new generation of antivenoms?].
    Aubrey N; Muzard J; Juste M; Billiald P
    J Soc Biol; 2006; 200(4):345-54. PubMed ID: 17652970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.
    Ben Abderrazek R; Ksouri A; Idoudi F; Dhaouadi S; Hamdi E; Vincke C; Farah A; Benlasfar Z; Majdoub H; El Ayeb M; Muyldermans S; Bouhaouala-Zahar B
    Front Immunol; 2022; 13():863012. PubMed ID: 35514999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom.
    Darvish M; Ebrahimi SA; Shahbazzadeh D; Bagheri KP; Behdani M; Shokrgozar MA
    Toxicon; 2016 Apr; 113():70-5. PubMed ID: 26809016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivenom for children with neurotoxicity from scorpion stings.
    Abroug F; Ouanes-Besbes L; ElAtrous S
    N Engl J Med; 2009 Aug; 361(6):631; author reply 632. PubMed ID: 19657132
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotherapy in the management of scorpion sting in children in Saudi Arabia.
    el-Amin EO; Sultan OM; al-Magamci MS; Elidrissy A
    Ann Trop Paediatr; 1994; 14(1):21-4. PubMed ID: 7516129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of scorpion sting.
    Laubscher HH
    S Afr Med J; 1983 Oct; 64(19):731. PubMed ID: 6623282
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of the scorpion envenoming syndrome: 12-years experience with serotherapy.
    Ismail M
    Int J Antimicrob Agents; 2003 Feb; 21(2):170-4. PubMed ID: 12615382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe scorpion envenomation in Brazil. Clinical, laboratory and anatomopathological aspects.
    Cupo P; Jurca M; Azeedo-Marques MM; Oliveira JS; Hering SE
    Rev Inst Med Trop Sao Paulo; 1994; 36(1):67-76. PubMed ID: 7997776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivenom for children with neurotoxicity from scorpion stings.
    Sofer S; Bawaskar HS; Gueron M
    N Engl J Med; 2009 Aug; 361(6):631-2; author reply 632. PubMed ID: 19662674
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation of F(ab')
    Ismael BN; Abass KS; Khalil KA; Salih KA
    Biologicals; 2018 Nov; 56():19-23. PubMed ID: 30153952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.